Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Ensysce Biosciences Stock News

ENSCWOTC

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$0.0200

At close: Aug 28, 9:14 AM EDT

$0.0310

0.0155.00%

After Hours: Aug 28, 9:14 AM EDT

Ensysce Biosciences (ENSCW) Forecast

News

Earnings Ensysce Biosciences (ENSCW) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Ensysce Biosciences Stock News | OTC:ENSCW | Benzinga

Get the latest news on Ensysce Biosciences stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Ensysce Biosciences performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Tuesday, October 24, 2023

Ensysce Biosciences Secures $1.7M Convertible Note Financing
Happy Mohamed

Monday, December 19, 2022

Ensysce Biosciences Announces Data From PF614...
Benzinga Newsdesk

Monday, December 05, 2022

Ensysce Biosciences Announces Completion Of C...
Benzinga Newsdesk

Monday, November 14, 2022

Ensysce Biosciences Announces FDA Guidance On...
Benzinga Newsdesk

Monday, October 31, 2022

Ensysce Biosciences Announces Topline Results...
Benzinga Newsdesk

Friday, October 28, 2022

Ensysce Biosciences Announces First Subjects ...
Benzinga Newsdesk

Thursday, September 22, 2022

Ensysce Biosciences Announces Initiation Of S...
Benzinga Newsdesk

Thursday, September 08, 2022

Ensysce Biosciences Announces Results of Spec...
Benzinga Newsdesk

Wednesday, August 31, 2022

Ensysce Biosciences And Quotient Sciences Ann...
Benzinga Newsdesk

Wednesday, July 13, 2022

Ensysce Biosciences Announces Initial Patients Dosed Of First Human Abuse Potential Study
Bill Haddad
Ensysce Biosciences Announces Initial Patients Dosed Of First Human Abuse Potential Study
Bill Haddad

Monday, May 23, 2022

Ensysce Biosciences Announces Initiation Of F...
Benzinga Newsdesk

Thursday, May 05, 2022

Ensysce Biosciences Announces New Clinical Re...
Benzinga Newsdesk

Monday, January 10, 2022

Ensysce Biosciences Announces First Cohort Do...
Benzinga Newsdesk

Tuesday, January 04, 2022

Ensysce Biosciences Reports Achieved Successf...
Benzinga Newsdesk

Wednesday, December 15, 2021

Ensysce Biosciences Announces First Patients ...
Benzinga Newsdesk

Tuesday, November 30, 2021

Ensysce Biosciences Announces Clinical Trial ...
Benzinga Newsdesk

Thursday, August 05, 2021

Ensysce Biosciences Highlights Notice Of Allo...
Benzinga Newsdesk

Thursday, July 01, 2021

Ensysce Biosciences To Begin Trading On Nasda...
Benzinga Newsdesk

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved